Determination of phagocytosis of Leishmania spp. by human polymorphonuclear leukocytes using anti-Leishmania monoclonal antibodies.
Phagocytosis of Leishmania is an early event in the capacity of human polymorphonuclear cells to limit the spread of this infectious agent. We compared two methods to assess the phagocytosis of Leishmania by PMN cells; the first using histochemical staining with Wright or Giemsa, and the second using the immunoperoxidase technique with anti-Leishmania monoclonal antibodies. The quantitative results obtained with either of the cytochemical methods were comparable with the immunoperoxidase technique, but the latter offered the advantage of an easier identification of the intracellular parasites. This improvement greatly reduced the time required to quantify phagocytosis compared to the conventional staining techniques.
Infante
R B
RB
Laboratorio de Inmunopatología, Instituto de Biomedica (Panamerican Center for Research Training in Leprosy and Tropical Diseases, PAHO-WHO), Central University of Venezuela, Caracas.
Pérez
M
M
Di Prisco-Fuenmayor
M C
MC
Badell
E
E
Lynch
N R
NR
D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D066298:In Vitro Techniques; D007891:Leishmania / Q000276:immunology*; D007892:Leishmania braziliensis / Q000276:immunology; D007894:Leishmania mexicana / Q000276:immunology; D016773:Leishmaniasis, Cutaneous / Q000276:immunology / Q000469:parasitology; D008297:Male; D009504:Neutrophils / Q000276:immunology* / Q000469:parasitology; D010587:Phagocytosis / Q000276:immunology*; D013194:Staining and Labeling / Q000379:methods
D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan